Checklist to be completed by the HCP in the penultimate appointment before patient transitions to adult ADHD services.

Checklist to be completed by the ADHD patient prior to their final appointment before they transition to adult ADHD services.

Expert talk by Prof. David Nutt examining the intersection of addiction and ADHD, discussing neurobiological mechanisms, comorbidity, and treatment approaches, with clinical anecdotes highlighting diagnostic complexities, the role of dopamine, and the impact of stimulant therapy on substance use and behavioural addictions.

Dr. Helen Tindle shares practical strategies for optimising ADHD care in teenagers, focusing on balanced treatment, real-world challenges, and the value of psychoeducation and personalised plans.

In this video Prof. Susan Young, explores ADHD in teenage girls—covering diagnostic challenges, symptom masking, and unique risks. Featuring case study discussions from Dr. Helen Tindle.

Dr. Chris Abbott explores ADHD and conduct disorder in youths, covering diagnosis, comorbidity, treatment strategies, and outcomes, with real case studies illustrating assessment challenges and the importance of optimising ADHD management.

This video explains the proposed mechanism of action of Elvanse (lisdexamfetamine dimesylate) in the treatment of ADHD.

This video describes the unique prodrug technology of Elvanse (lisdexamfetamine dimesylate), explaining its unique delivery mechanism, conversion process in red blood cells, and factors affecting its bioavailability.

This video explains the proposed mechanism of action of INTUNIV®▼ (guanfacine hydrochloride) in the treatment of ADHD.